UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 31, 2018
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
(Exact name of Registrant as Specified in Its Charter)
|
Delaware |
001-35547 |
36-4392754 |
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
222 Merchandise Mart Plaza, Suite 2024,
Chicago, Illinois 60654
(Address of Principal Executive Offices) (Zip Code)
Registrant’s Telephone Number, Including Area Code: (312) 506-1200
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 31, 2018, it was announced that Mr. Dennis M. Olis, who has been serving as interim Chief Financial Officer of Allscripts Healthcare Solutions, Inc. (the “Company”) since May 12, 2017, was appointed as Chief Financial Officer of the Company, effective immediately, removing the “interim” designation from his position. There have been no other changes to Mr. Olis’s compensation or employment arrangements. Further information regarding Mr. Olis is set forth under the heading “Appointment of Interim Chief Financial Officer” in Item 5.02 of that Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on May 12, 2017, and such information is incorporated herein by reference.
Item 7.01.Regulation FD Disclosure
On January 31, 2018, the Company issued a press release announcing Mr. Olis’s appointment as Chief Financial Officer of the Company, removing the “interim” designation from his position. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
The information furnished pursuant to this Item shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01.Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release issued by Allscripts Healthcare Solutions, Inc. on January 31, 2018. |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. |
|
|
Date: January 31, 2018 |
|
|
|
|
By: |
/s/ Brian P. Farley |
|
|
|
Brian P. Farley Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary |
2
Exhibit 99.1
Allscripts Names Dennis Olis Chief Financial Officer
CHICAGO – January 31, 2018 – Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) announced Dennis Olis has been named Chief Financial Officer of the Company, effective January 31, 2018. Since May of 2017, Olis has been serving as Allscripts interim Chief Financial Officer.
Olis will oversee Allscripts finance functions including controllership, tax, internal audit, financial planning and analysis, treasury and investor relations. He will report to Allscripts Chief Executive Officer, Paul Black.
"We are delighted to officially announce Dennis Olis as Allscripts Chief Financial Officer," said Black. "Dennis’s experience in a variety of finance and operational leadership roles, paired with his accomplishments as Allscripts interim Chief Financial Officer, solidifies our decision to have him permanently take on this role. I look forward to continuing to work with Dennis to execute on Allscripts growth plans.”
Olis joined Allscripts in November 2012 as the Company’s Senior Vice President, Operations. From November 2016 to May 2017, he served as Allscripts Senior Vice President, Strategic Initiatives.
Olis earned a bachelor’s degree in finance from Marquette University and a master’s degree in business administration and accounting from DePaul University.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
###
© 2018 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Dennis Olis
312-386-6700
dennis.olis@allscripts.com
Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. See our Annual Report on Form 10-K for 2016 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.